FDA Approves Veppanu From Arvinas and Pfizer, the First Protein-Degrader Drug Cleared for Any Cancer
Vepdegestrant becomes the first PROTAC ever approved by the FDA, treating ESR1-mutated advanced breast cancer after one prior endocrine therapy.
3 min read2 sources